BR0111248A - Derivados de ácido quinolonacarboxìlico - Google Patents

Derivados de ácido quinolonacarboxìlico

Info

Publication number
BR0111248A
BR0111248A BR0111248-1A BR0111248A BR0111248A BR 0111248 A BR0111248 A BR 0111248A BR 0111248 A BR0111248 A BR 0111248A BR 0111248 A BR0111248 A BR 0111248A
Authority
BR
Brazil
Prior art keywords
acid derivatives
fluoro
quinolonecarboxylic acid
antibacterial
compound
Prior art date
Application number
BR0111248-1A
Other languages
English (en)
Inventor
Makoto Takemura
Hisashi Takahashi
Katsuhiro Kawakami
Masao Itoh
Tetsuya Suzuki
Tsuyoshi Ohtani
Masayasu Sekiguchi
Rie Miyauchi
Isao Hayakawa
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of BR0111248A publication Critical patent/BR0111248A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"DERIVADOS DE áCIDO QUINOLONACARBOXìLICO". ácido (-)-7-[(7S)-7-amino-5-azaespiro [2.4] heptan -5-il]-6-fluoro-1-[(1R, 2S)-2-fluoro-1-ciclopropil] -1,4-di-hidro-8-metóxi-4-oxo-3-quinolina carboxílico. 1HC1. 1H~ 2~O e composições antibacterianas contendo este composto. O composto resultante da presente invenção apresenta não somente excelente atividade antibacteriana e segurança, mas também estabilidade notável a luz e umidade, e é assim útil como agente antibacteriano.
BR0111248-1A 2000-03-31 2001-03-30 Derivados de ácido quinolonacarboxìlico BR0111248A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000097690 2000-03-31
JP2000271231 2000-09-07
PCT/JP2001/002761 WO2001072738A1 (en) 2000-03-31 2001-03-30 Quinolonecarboxylic acid derivative

Publications (1)

Publication Number Publication Date
BR0111248A true BR0111248A (pt) 2003-07-08

Family

ID=26589134

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111248-1A BR0111248A (pt) 2000-03-31 2001-03-30 Derivados de ácido quinolonacarboxìlico

Country Status (13)

Country Link
US (2) US6900225B2 (pt)
EP (1) EP1298131A4 (pt)
CN (1) CN1432008A (pt)
AR (1) AR027761A1 (pt)
AU (2) AU2001244671B2 (pt)
BR (1) BR0111248A (pt)
CA (1) CA2408806A1 (pt)
IL (1) IL152759A0 (pt)
MX (1) MXPA02011671A (pt)
NO (1) NO20025542L (pt)
NZ (1) NZ522667A (pt)
RU (1) RU2002135315A (pt)
WO (1) WO2001072738A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
ATE407121T1 (de) * 2000-02-09 2008-09-15 Daiichi Sankyo Co Ltd Gegen säurebeständige bakterien wirksame antibakterielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten
JPWO2003076428A1 (ja) * 2002-03-08 2005-07-07 第一製薬株式会社 キノロンカルボン酸誘導体
WO2003097634A1 (en) * 2002-05-17 2003-11-27 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acid derivative
WO2004108680A1 (ja) * 2003-06-06 2004-12-16 Daiichi Pharmaceutical Co., Ltd. 光学活性なキノロンカルボン酸誘導体の製造中間体およびその製造法
JP4619952B2 (ja) * 2003-09-29 2011-01-26 第一三共株式会社 ８−シアノキノロンカルボン酸誘導体
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
TWI386401B (zh) * 2006-03-27 2013-02-21 Daiichi Seiyaku Co 醫藥用水合物
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
CN101361739B (zh) * 2007-08-09 2012-03-14 太景生物科技股份有限公司 抗菌剂的肠胃外制剂
US8680271B2 (en) * 2010-03-26 2014-03-25 Merck Sharp & Dohme Corp. Process for synthesizing 6-bromo-3-1-(1-methyl-1H-pyrazol-4-yl)-5-(3(R)-piperidinyl)pyrazolo[1,5-a]pyrimidin-7-amine
EP2602253A4 (en) 2010-08-06 2014-01-01 Daiichi Sankyo Co Ltd CRYSTAL OF AN ANTIBACTERIAL CONNECTION
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY105136A (en) 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
US5286723A (en) 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
JPH0649059A (ja) * 1992-07-23 1994-02-22 Hokuriku Seiyaku Co Ltd ７−（５−アザスピロ〔２，４〕ヘプタン−５−イル）−８−アルコキシキノリン−３−カルボン酸誘導体
JPH06199834A (ja) * 1993-01-08 1994-07-19 Hokuriku Seiyaku Co Ltd 光学活性な８−メトキシキノリン−３−カルボン酸誘導体
DK0807630T3 (da) * 1995-02-02 2003-09-01 Daiichi Seiyaku Co Heterocykliske forbindelser
JP4302205B2 (ja) * 1998-07-14 2009-07-22 第一三共株式会社 感染症治療薬

Also Published As

Publication number Publication date
EP1298131A1 (en) 2003-04-02
US20030187008A1 (en) 2003-10-02
RU2002135315A (ru) 2004-05-27
IL152759A0 (en) 2003-06-24
AU2001244671B2 (en) 2005-01-27
MXPA02011671A (es) 2003-03-27
EP1298131A4 (en) 2004-09-08
US20040142957A1 (en) 2004-07-22
NO20025542D0 (no) 2002-11-19
CA2408806A1 (en) 2001-10-04
AR027761A1 (es) 2003-04-09
US6900225B2 (en) 2005-05-31
NZ522667A (en) 2004-06-25
AU4467101A (en) 2001-10-08
WO2001072738A1 (en) 2001-10-04
CN1432008A (zh) 2003-07-23
NO20025542L (no) 2002-11-26

Similar Documents

Publication Publication Date Title
DE50011582D1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
UA82980C2 (ru) Замещенные амиды бензойной кислоты и их применение для угнетения ангиогенеза
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
BR0210028A (pt) Agentes antibacterianos
AU5960101A (en) Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
DE60031025D1 (de) Verwendung von Cubebol als Aromastoff
ES2183473T3 (es) Derivados de acido piridonacarboxilico como agentes antibacterianos.
HN1999000124A (es) Derivados de pirazol substituido.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ES2105913T3 (es) Composiciones para el teñido de las fibras queratinicas que comprenden un orto-diamino pirazol y una sal de manganeso, procedimiento de teñido que utiliza estas composiciones.
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
BR0114252A (pt) Derivados de nitrosodifenilamina
IL190905A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acids and processes for their prepatation
BR0213464A (pt) Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
ES2192668T3 (es) Compuestos biciclicos-aromaticos.
ES2179332T3 (es) Repelentes de artropodos.
BRPI0413964B8 (pt) ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial
EP1298131A4 (en) QUINOLONE-CARBOXYLIC ACID DERIVATIVE
SE9901077D0 (sv) Novel use
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
DE50105075D1 (de) Oxidationsfärbemittel

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.